Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein for Inflammation in COVID-19
NCT05226754Phase 2Unknown
- Sponsor
- Universidade Estadual de Campinas
- Start
- Apr 2022
- Primary completion
- Jun 2023
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of diacerein in coronavirus disease 2019 (COVID-19), sponsored by Universidade Estadual de Campinas. Status: unknown.
02
Drugs
diacerein
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05226754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05226754.